The Role of Metabolomics in Personalized Medicine for Diabetes

References

• American Diabetes Association . Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care42(Suppl. 1), S13–S28 (2019).
   PubMed Web of Science ®Google Scholar
• Esser N , UtzschneiderKM , KahnSE. Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia63(10), 2007–2021 (2020).
   PubMed Web of Science ®Google Scholar
• Hu FB , SatijaA , MansonJE. Curbing the diabetes pandemic: the need for global policy solutions. JAMA313(23), 2319–2320 (2015).
   PubMed Web of Science ®Google Scholar
• Nawaz SS , UsmaniAM , SiddiquiK. Specialized biobank for diabetes research: current prospect. Int. J. Med. Dev. Ctries2(1), 1–8 (2018).
   Google Scholar
• Serkova NJ , StandifordTJ , StringerKA. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am. J. Respir. Crit. Care Med.184(6), 647–655 (2011).
   PubMed Web of Science ®Google Scholar
• Pallares-Méndez R , Aguilar-SalinasCA , Cruz-BautistaIet al. Metabolomics in diabetes, a review. Ann. Med.48(1–2), 89–102 (2016).
   PubMed Web of Science ®Google Scholar
• Nicholson JK , ConnellyJ , LindonJCet al. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov.1(2), 153–161 (2002).
   PubMed Web of Science ®Google Scholar
• Shulaev V . Metabolomics technology and bioinformatics. Brief Bioinform.7(2), 128–139 (2006).
   PubMed Web of Science ®Google Scholar
• Spratlin JL , SerkovaNJ , EckhardtSG. Clinical applications of metabolomics in oncology: a review. Clin. Cancer Res.15(2), 431–440 (2009).
   PubMed Web of Science ®Google Scholar
• Azad RK , ShulaevV. Metabolomics technology and bioinformatics for precision medicine. Brief Bioinform.20(6), 1957–1971 (2019).
   PubMed Web of Science ®Google Scholar
• Suhre K . Metabolic profiling in diabetes. J. Endocrinol.221(3), R75–R85 (2014).
   PubMed Web of Science ®Google Scholar
• Sas KM , KarnovskyA , MichailidisGet al. Metabolomics and diabetes: analytical and computational approaches. Diabetes64(3), 718–732 (2015).
   PubMed Web of Science ®Google Scholar
• Li B , HeX , JiaW , LiH. Novel applications of metabolomics in personalized medicine: a mini-review. Molecules22(7), 1173 (2017).
   PubMed Web of Science ®Google Scholar
• Salari K . The dawning era of personalized medicine exposes a gap in medical education. PLoS Med.6(8), e1000138 (2009).
   PubMed Web of Science ®Google Scholar
• Abrahams E . Right drug – right patient – right time: personalized medicine coalition. Clin. Transl. Sci.1(1), 11 (2008).
   PubMed Web of Science ®Google Scholar
• Tam ZY , NgSP , TanLQet al. Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus. Sci. Rep.7(1), 1–12 (2017).
   PubMedGoogle Scholar
• Pinu FR , Villas-BoasSG , AggioR. Analysis of intracellular metabolites from microorganisms: quenching and extraction protocols. Metabolites7(4), 53 (2017).
   PubMed Web of Science ®Google Scholar
• Swellam M , Abdel-FatahAli A. Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus. Dis. Markers27(6), 269–278 (2009).
   PubMed Web of Science ®Google Scholar
• Samira S , BroecklingCD , GannaAet al. Non-targeted urine metabolomics and associations with prevalent and incident type 2 diabetes. Sci. Rep.10(1), 1–9 (2020).
   PubMed Web of Science ®Google Scholar
• Al-Sulaiti H , DibounI , AghaMVet al. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes. J. Transl. Med.17(1), 1–11 (2019).
   PubMed Web of Science ®Google Scholar
• Ahola-Olli AV , MustelinL , KalimeriMet al. Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts. Diabetologia62(12), 2298–2309 (2019).
   PubMed Web of Science ®Google Scholar
• Yang SJ , KwakSY , JoG , SongTJ , ShinMJ. Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study. Sci. Rep.8(1), 1–10 (2018).
   PubMed Web of Science ®Google Scholar
• Cobb J , EckhartA , Motsinger-ReifA , CarrB , GroopL , FerranniniE. α-Hydroxybutyric acid is a selective metabolite biomarker of impaired glucose tolerance. Diabetes Care39(6), 988–995 (2016).
   PubMed Web of Science ®Google Scholar
• Allalou A , NallaA , PrenticeKJet al. A predictive metabolic signature for the transition from gestational diabetes mellitus to type 2 diabetes. Diabetes65(9), 2529–2539 (2016).
   PubMed Web of Science ®Google Scholar
• Lu Y , WangY , OngC-Net al. Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS. Diabetologia59(11), 2349–2359 (2016).
   PubMed Web of Science ®Google Scholar
• Palmer ND , StevensRD , AntinozziPAet al. Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. J. Clin. Endocrinol. Metab.100(3), E463–E468 (2015).
   PubMed Web of Science ®Google Scholar
• Cobb J , EckhartA , PerichonRet al. A novel test for IGT utilizing metabolite markers of glucose tolerance. J. Diabetes Sci. Technol.9(1), 69–76 (2014).
   PubMedGoogle Scholar
• Krebs M , KrssakM , BernroiderEet al. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes51(3), 599–605 (2002).
   PubMed Web of Science ®Google Scholar
• Yamanouchi T , OgataN , TagayaTet al. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet347(9014), 1514–1518 (1996).
   PubMed Web of Science ®Google Scholar
• Wang TJ , LarsonMG , VasanRSet al. Metabolite profiles and the risk of developing diabetes. Nat. Med.17(4), 448–453 (2011).
   PubMed Web of Science ®Google Scholar
• Nawaz SS , SiddiquiK. The emerging role of branch chain amino acids in the prediction of diabetes: a brief review. Curr. Diabetes Rev.16(6), 532–537 (2020).
   PubMed Web of Science ®Google Scholar
• Deo RC , HunterL , LewisGDet al. Interpreting metabolomic profiles using unbiased pathway models. PLoS Comput. Biol.6(2), e1000692 (2010).
   PubMed Web of Science ®Google Scholar
• Altmaier E , RamsaySL , GraberAet al. Bioinformatics analysis of targeted metabolomics – uncovering old and new tales of diabetic mice under medication. Endocrinology149(7), 3478–3489 (2008).
   PubMed Web of Science ®Google Scholar
• Suhre K , Römisch-MarglW , DeAngelis MHet al. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing. J. Biomol. Screen.16(5), 467–475 (2011).
   PubMedGoogle Scholar
• Kleinberger JW , PollinTI. Personalized medicine in diabetes mellitus: current opportunities and future prospects. Ann. NY Acad. Sci.1346(1), 45 (2015).
   PubMed Web of Science ®Google Scholar
• Suhre K , MeisingerC , DöringAet al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE5(11), e13953 (2010).
   PubMed Web of Science ®Google Scholar
• Jacob M , LopataAL , DasoukiMet al. Metabolomics toward personalized medicine. Mass Spectrom. Rev.38(3), 221–238 (2019).
   PubMed Web of Science ®Google Scholar
• Chung WK , ErionK , FlorezJCet al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care43(7), 1617–1635
   PubMed Web of Science ®Google Scholar
• Klonoff DC , FlorezJC , GermanMet al. The need for precision medicine to be applied to diabetes. J. Diabetes Sci. Technol.14(6), 1122–1128 (2020).
   PubMedGoogle Scholar